Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apyx Medical, Ascensia Diabetes Care, Snaq, Bracco Imaging, Eisai, Electrocore, Byond Healthcare, Hatch Medical, Endobar Solutions, Maternova, Medmira.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Glycomark, Masimo, Precision Diabetes.

Med-tech firms raising money in public or private financings, including: Mirion Technologies, Xeltis.

New hires and promotions in the med-tech industry, including: Casana, Delphinus, Lex Diagnostics, Medidata, Precisedx, Tactile Systems.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alterity, Apellis, Astellas, Chiesi, CSL, Iveric, Karyopharm, Menarini, Merck, Moderna, Specialised, Teva, Travere, Uniqure.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adimmune, Aileron, Awakn, Biocytogen, Biosenic, Celltrion, Clover, ICER, Ligand, Liscure, Machine Bio, Myeloid, Pregene, Travere.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amniotics, Jasper, Merck, Moderna, NS, Orion, Pfizer, Sarepta, Theriva, Valneva.

New hires and promotions in the biopharma industry, including: Anixa, Brim, Jasper, Novartis, Oxford Biomedica, Preveceutical, Shoreline.

Biopharmas raising money in public or private financings, including: Bavarian Nordic, Checkpoint, Esperas, Mymd, Nfl, Transcode, Verrica.